FindTrial
Sign In

Comparing biometric factors in short eyes versus normal eyes

Comparison of Ocular biometric Parameters in Patients diagnosed with Nanophthalmos and in patients with Primary Angle Closure Disease - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075304
Enrollment
150
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

Intervention1: Patients diagnosed with Nanophthalmos: One time intervention of 30 to 40 minutes duration Control Intervention1: Patients diagnosed with Primary Angle Closure Disease: One time interven

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with nanophthalmos - study group Diagnosed with primary angle closure disease -control group

Exclusion criteria

Exclusion criteria: 1) Patients with corneal opacities 2) Patients who have undergone YAG peripheral iridotomy or cataract surgery

Design outcomes

Primary

MeasureTime frame
To analyze the ocular biometric parameters in patients with Nanophthalmos and in patients with Primary Angle Closure disease Timepoint: 6 months—

Secondary

MeasureTime frame
It may further support the continuation of understanding the risk factors with a large population Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr N Venkatesh Prajna

Aravind Eye Hospital and Postgraduate Institute of Ophthalmology

prajna@aravind.org914524356100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026